{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T15:04:09Z","timestamp":1786115049573,"version":"build-2736575974"},"reference-count":55,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Immunology and Allergy Clinics of North America"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.iac.2026.04.013","type":"journal-article","created":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T23:25:42Z","timestamp":1783639542000},"page":"543-549","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Management of Atopic Hand Dermatitis"],"prefix":"10.1016","volume":"46","author":[{"given":"Lauren R.","family":"Port","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick M.","family":"Brunner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.iac.2026.04.013_bib1","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.jaad.2023.04.052","article-title":"Prevalence and burden of atopic dermatitis involving the head, neck, face, and hand: A cross sectional study from the TARGET-DERM AD cohort","volume":"89","author":"Silverberg","year":"2023","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"10.1016\/j.iac.2026.04.013_bib2","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.mcna.2021.04.003","article-title":"Diagnosis and Management of Dermatitis, Including Atopic, Contact, and Hand Eczemas","volume":"105","author":"Chan","year":"2021","journal-title":"Med Clin North Am"},{"issue":"Suppl 1","key":"10.1016\/j.iac.2026.04.013_bib3","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1159\/000370220","article-title":"Atopic dermatitis: global epidemiology and risk factors","volume":"66","author":"Nutten","year":"2015","journal-title":"Ann Nutr Metab"},{"issue":"1","key":"10.1016\/j.iac.2026.04.013_bib4","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1080\/1744666X.2016.1212660","article-title":"Environmental risk factors and their role in the management of atopic dermatitis","volume":"13","author":"Kantor","year":"2017","journal-title":"Expet Rev Clin Immunol"},{"issue":"5","key":"10.1016\/j.iac.2026.04.013_bib5","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1016\/j.jaci.2022.10.023","article-title":"Novel insights into atopic dermatitis","volume":"151","author":"Schuler","year":"2023","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.iac.2026.04.013_bib6","article-title":"Diversity of atopic dermatitis and selection of immune targets","author":"Rothenberg-Lausell","year":"2023","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"3","key":"10.1016\/j.iac.2026.04.013_bib7","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1007\/s12016-021-08880-3","article-title":"Update on the Pathogenesis and Therapy of Atopic Dermatitis","volume":"61","author":"Li","year":"2021","journal-title":"Clin Rev Allergy Immunol"},{"issue":"2","key":"10.1016\/j.iac.2026.04.013_bib8","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.anai.2023.09.009","article-title":"Filaggrin and beyond: New insights into the skin barrier in atopic dermatitis and allergic diseases, from genetics to therapeutic perspectives","volume":"132","author":"Stefanovic","year":"2024","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"3","key":"10.1016\/j.iac.2026.04.013_bib9","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1111\/cea.12495","article-title":"Pathogenesis of atopic dermatitis","volume":"45","author":"Peng","year":"2015","journal-title":"Clin Exp Allergy"},{"issue":"5","key":"10.1016\/j.iac.2026.04.013_bib10","doi-asserted-by":"crossref","first-page":"100131","DOI":"10.1016\/j.xjidi.2022.100131","article-title":"Type 2 Inflammation Contributes to Skin Barrier Dysfunction in Atopic Dermatitis","volume":"2","author":"Beck","year":"2022","journal-title":"JID Innov"},{"issue":"378","key":"10.1016\/j.iac.2026.04.013_bib11","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aah4680","article-title":"Antimicrobials from human skin commensal bacteria protect against Staphylococcus aureus and are deficient in atopic dermatitis","volume":"9","author":"Nakatsuji","year":"2017","journal-title":"Sci Transl Med"},{"issue":"4","key":"10.1016\/j.iac.2026.04.013_bib12","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1111\/bjd.16147","article-title":"The association between atopic dermatitis and hand eczema: a systematic review and meta-analysis","volume":"178","author":"Ruff","year":"2018","journal-title":"Br J Dermatol"},{"issue":"1","key":"10.1016\/j.iac.2026.04.013_bib13","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1007\/s12016-018-8706-z","article-title":"Occupational and Hand Dermatitis: a Practical Approach","volume":"56","author":"Lampel","year":"2019","journal-title":"Clin Rev Allergy Immunol"},{"issue":"1","key":"10.1016\/j.iac.2026.04.013_bib14","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.anai.2021.08.007","article-title":"Hand hygiene impact on the skin barrier in health care workers and individuals with atopic dermatitis","volume":"128","author":"Hui-Beckman","year":"2022","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"3","key":"10.1016\/j.iac.2026.04.013_bib15","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1111\/cod.14102","article-title":"Lifestyle factors and hand eczema: A systematic review and meta-analysis of observational studies","volume":"87","author":"Loman","year":"2022","journal-title":"Contact Dermatitis"},{"issue":"1","key":"10.1016\/j.iac.2026.04.013_bib16","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25010362","article-title":"New perspectives in the management of chronic hand eczema: lessons from pathogenesis","volume":"25","author":"Tancredi","year":"2023","journal-title":"Int J Mol Sci"},{"issue":"7","key":"10.1016\/j.iac.2026.04.013_bib17","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1038\/sj.jid.5700750","article-title":"Heritability of hand eczema is not explained by comorbidity with atopic dermatitis","volume":"127","author":"Lerbaek","year":"2007","journal-title":"J Invest Dermatol"},{"issue":"2","key":"10.1016\/j.iac.2026.04.013_bib18","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1111\/j.1600-0536.2009.01669.x","article-title":"The epidemiology of hand eczema in the general population--prevalence and main findings","volume":"62","author":"Thyssen","year":"2010","journal-title":"Contact Dermatitis"},{"issue":"5","key":"10.1016\/j.iac.2026.04.013_bib19","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1007\/s40271-019-00373-y","article-title":"Patient-reported outcome measures in atopic dermatitis and chronic hand eczema in adults","volume":"12","author":"Barrett","year":"2019","journal-title":"Patient"},{"issue":"3","key":"10.1016\/j.iac.2026.04.013_bib20","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1097\/DER.0000000000000598","article-title":"Impact of atopic dermatitis and chronic hand eczema on quality of life compared with other chronic diseases","volume":"31","author":"Capucci","year":"2020","journal-title":"Dermatitis"},{"issue":"6","key":"10.1016\/j.iac.2026.04.013_bib21","doi-asserted-by":"crossref","first-page":"749","DOI":"10.2340\/00015555-1584","article-title":"Atopic dermatitis and non-atopic hand eczema have similar negative impacts on quality of life: implications for clinical significance","volume":"93","author":"Chen","year":"2013","journal-title":"Acta Derm Venereol"},{"issue":"1","key":"10.1016\/j.iac.2026.04.013_bib22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41572-018-0001-z","article-title":"Atopic dermatitis","volume":"4","author":"Weidinger","year":"2018","journal-title":"Nat Rev Dis Primers"},{"issue":"4","key":"10.1016\/j.iac.2026.04.013_bib23","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1111\/j.1600-0536.1999.tb06131.x","article-title":"Histological distinction between early allergic and irritant patch test reactions: follicular spongiosis may be characteristic of early allergic contact dermatitis","volume":"41","author":"Vestergaard","year":"1999","journal-title":"Contact Dermatitis"},{"issue":"1","key":"10.1016\/j.iac.2026.04.013_bib24","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1097\/DAD.0000000000000842","article-title":"Histomorphology and Immunophenotype of Eczematous Skin Lesions Revisited-Skin Biopsies Are Not Reliable in Differentiating Allergic Contact Dermatitis, Irritant Contact Dermatitis, and Atopic Dermatitis","volume":"40","author":"Frings","year":"2018","journal-title":"Am J Dermatopathol"},{"issue":"5","key":"10.1016\/j.iac.2026.04.013_bib25","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1097\/DER.0000000000000659","article-title":"Chronic Hand Eczema Guidelines From an Expert Panel of the International Eczema Council","volume":"32","author":"Silverberg","year":"2021","journal-title":"Dermatitis"},{"issue":"12","key":"10.1016\/j.iac.2026.04.013_bib26","doi-asserted-by":"crossref","first-page":"e15901","DOI":"10.1111\/dth.15901","article-title":"Children atopic dermatitis: Diagnosis, mimics, overlaps, and therapeutic implication","volume":"35","author":"Napolitano","year":"2022","journal-title":"Dermatol Ther"},{"issue":"4","key":"10.1016\/j.iac.2026.04.013_bib27","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/s00403-011-1198-9","article-title":"Association of serum interleukin-18 and other biomarkers with disease severity in adults with atopic dermatitis","volume":"304","author":"Kou","year":"2012","journal-title":"Arch Dermatol Res"},{"issue":"5","key":"10.1016\/j.iac.2026.04.013_bib28","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1097\/ACI.0b013e32830e71a7","article-title":"The impact of allergy on atopic eczema from data from epidemiological studies","volume":"8","author":"Schafer","year":"2008","journal-title":"Curr Opin Allergy Clin Immunol"},{"issue":"5","key":"10.1016\/j.iac.2026.04.013_bib29","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1046\/j.1365-2133.2000.03832.x","article-title":"The excess of atopic eczema in East Germany is related to the intrinsic type","volume":"143","author":"Schafer","year":"2000","journal-title":"Br J Dermatol"},{"issue":"1","key":"10.1016\/j.iac.2026.04.013_bib30","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.jaci.2004.04.027","article-title":"How atopic is atopic dermatitis?","volume":"114","author":"Flohr","year":"2004","journal-title":"J Allergy Clin Immunol"},{"issue":"7","key":"10.1016\/j.iac.2026.04.013_bib31","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1111\/j.1398-9995.2009.01952.x","article-title":"Food allergy and food sensitization in early childhood: results from the DARC cohort","volume":"64","author":"Eller","year":"2009","journal-title":"Allergy"},{"issue":"5","key":"10.1016\/j.iac.2026.04.013_bib32","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/j.jaad.2022.07.035","article-title":"Hand and foot dermatitis in patients referred for patch testing: Analysis of North American Contact Dermatitis Group Data, 2001-2018","volume":"87","author":"Silverberg","year":"2022","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"10.1016\/j.iac.2026.04.013_bib33","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1111\/jdv.14016","article-title":"Factors associated with combined hand and foot eczema","volume":"31","author":"Agner","year":"2017","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"1","key":"10.1016\/j.iac.2026.04.013_bib34","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1684\/ejd.2022.4234","article-title":"Chronic hand eczema: clinical characterization, aetiology, concomitant foot eczema and polysensitization","volume":"32","author":"Lopez-Castillo","year":"2022","journal-title":"Eur J Dermatol"},{"issue":"1","key":"10.1016\/j.iac.2026.04.013_bib35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jaci.2018.10.032","article-title":"Atopic dermatitis endotypes and implications for targeted therapeutics","volume":"143","author":"Czarnowicki","year":"2019","journal-title":"J Allergy Clin Immunol"},{"issue":"3","key":"10.1016\/j.iac.2026.04.013_bib36","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.det.2017.02.010","article-title":"Management of Atopic Hand Dermatitis","volume":"35","author":"Halling-Overgaard","year":"2017","journal-title":"Dermatol Clin"},{"issue":"4","key":"10.1016\/j.iac.2026.04.013_bib37","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/s40257-015-0130-z","article-title":"Hand dermatitis: a review of clinical features, prevention and treatment","volume":"16","author":"Antonov","year":"2015","journal-title":"Am J Clin Dermatol"},{"issue":"1","key":"10.1016\/j.iac.2026.04.013_bib38","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.iac.2016.08.003","article-title":"Wet Wrap Therapy in Moderate to Severe Atopic Dermatitis","volume":"37","author":"Nicol","year":"2017","journal-title":"Immunol Allergy Clin North Am"},{"key":"10.1016\/j.iac.2026.04.013_bib39","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.2147\/TCRM.S292504","article-title":"Drugs for the Treatment of Chronic Hand Eczema: Successes and Key Challenges","volume":"16","author":"Dubin","year":"2020","journal-title":"Ther Clin Risk Manag"},{"issue":"8","key":"10.1016\/j.iac.2026.04.013_bib40","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1080\/13543784.2022.2087059","article-title":"Current emerging and investigational drugs for the treatment of chronic hand eczema","volume":"31","author":"Cheng","year":"2022","journal-title":"Expert Opin Investig Drugs"},{"issue":"6","key":"10.1016\/j.iac.2026.04.013_bib41","doi-asserted-by":"crossref","first-page":"e141","DOI":"10.1097\/DER.0000000000000793","article-title":"Topical Crisaborole in the Treatment of Atopic Hand Dermatitis: A Retrospective Chart Review","volume":"32","author":"Kahn","year":"2021","journal-title":"Dermatitis"},{"issue":"5","key":"10.1016\/j.iac.2026.04.013_bib42","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1177\/12034754231188325","article-title":"A Review of Existing and New Treatments for the Management of Hand Eczema","volume":"27","author":"Ho","year":"2023","journal-title":"J Cutan Med Surg"},{"issue":"4","key":"10.1016\/j.iac.2026.04.013_bib43","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1080\/1744666X.2023.2174526","article-title":"Topical and systemic JAK inhibitors in hand eczema - a narrative review","volume":"19","author":"Zalewski","year":"2023","journal-title":"Expet Rev Clin Immunol"},{"issue":"1","key":"10.1016\/j.iac.2026.04.013_bib44","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1111\/bjd.21037","article-title":"The pan-JAK inhibitor delgocitinib in a cream formulation demonstrates dose response in chronic hand eczema in a 16-week randomized phase IIb trial","volume":"187","author":"Worm","year":"2022","journal-title":"Br J Dermatol"},{"issue":"8","key":"10.1016\/j.iac.2026.04.013_bib45","doi-asserted-by":"crossref","first-page":"e447","DOI":"10.1111\/ijd.13205","article-title":"Use of 308 nm excimer laser for the treatment of chronic hand and foot eczema","volume":"55","author":"Shroff","year":"2016","journal-title":"Int J Dermatol"},{"issue":"8","key":"10.1016\/j.iac.2026.04.013_bib46","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1080\/1744666X.2021.1940962","article-title":"The IL-4, IL-13 and IL-31 pathways in atopic dermatitis","volume":"17","author":"Dubin","year":"2021","journal-title":"Expert Rev Clin Immunol"},{"issue":"24","key":"10.1016\/j.iac.2026.04.013_bib47","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1056\/NEJMoa1610020","article-title":"Two Phase 3 Trials of Dupilumab versus Placebo in Atopic Dermatitis","volume":"375","author":"Simpson","year":"2016","journal-title":"N Engl J Med"},{"issue":"8","key":"10.1016\/j.iac.2026.04.013_bib48","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1111\/1346-8138.14982","article-title":"Effect of dupilumab on hand eczema in patients with atopic dermatitis: An observational study","volume":"46","author":"Oosterhaven","year":"2019","journal-title":"J Dermatol"},{"issue":"6","key":"10.1016\/j.iac.2026.04.013_bib49","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1016\/j.jaad.2023.12.066","article-title":"Dupilumab treatment improves signs, symptoms, quality of life, and work productivity in patients with atopic hand and foot dermatitis: Results from a phase 3, randomized, double-blind, placebo-controlled trial","volume":"90","author":"Simpson","year":"2024","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"10.1016\/j.iac.2026.04.013_bib50","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1177\/10600280221105686","article-title":"Review of Tralokinumab in the Treatment of Atopic Dermatitis","volume":"57","author":"Singh","year":"2023","journal-title":"Ann Pharmacother"},{"issue":"1","key":"10.1016\/j.iac.2026.04.013_bib51","doi-asserted-by":"crossref","first-page":"46","DOI":"10.5021\/ad.2021.33.1.46","article-title":"Alitretinoin Compliance in Patients with Chronic Hand Eczema","volume":"33","author":"Seol","year":"2021","journal-title":"Ann Dermatol"},{"issue":"2","key":"10.1016\/j.iac.2026.04.013_bib52","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.jaad.2023.04.027","article-title":"Oral spleen tyrosine kinase\/Janus Kinase inhibitor gusacitinib for the treatment of chronic hand eczema: Results of a randomized phase 2 study","volume":"89","author":"Jimenez","year":"2023","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"10.1016\/j.iac.2026.04.013_bib53","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1111\/ajd.14074","article-title":"Nine cases of chronic hand and foot eczema treated with baricitinib","volume":"64","author":"Lee","year":"2023","journal-title":"Australas J Dermatol"},{"issue":"9","key":"10.1016\/j.iac.2026.04.013_bib54","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1111\/jdv.19194","article-title":"Effect of upadacitinib on atopic hand eczema in patients with moderate-to-severe atopic dermatitis: Results from two randomized phase 3 trials","volume":"37","author":"Simpson","year":"2023","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.iac.2026.04.013_bib55","doi-asserted-by":"crossref","first-page":"adv19454","DOI":"10.2340\/actadv.v104.19454","article-title":"Real-world Experience of Abrocitinib Treatment in Patients with Atopic Dermatitis and Hand Eczema: Up to 28-week Results from the BioDay Registry","volume":"104","author":"Kamphuis","year":"2024","journal-title":"Acta Derm Venereol"}],"container-title":["Immunology and Allergy Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S088985612600041X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S088985612600041X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T23:58:43Z","timestamp":1785974323000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S088985612600041X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":55,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["S088985612600041X"],"URL":"https:\/\/doi.org\/10.1016\/j.iac.2026.04.013","relation":{},"ISSN":["0889-8561"],"issn-type":[{"value":"0889-8561","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Management of Atopic Hand Dermatitis","name":"articletitle","label":"Article Title"},{"value":"Immunology and Allergy Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.iac.2026.04.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}